Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Triamcinolone with or without verapamil for postoperative keloid scars
IRCT20210524051384N6Phase 3Completed
- Sponsor
- Guilan University of Medical Sciences
- Start
- Nov 2021
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial in keloid comparing Triamcinolone group with Triamcinolone and verapamil group (2 arms). Primary endpoints: Keloid size, Itching severity and 1 more. Started Nov 2021; status: completed.
02
Drugs
triamcinoloneverapamil
03
Conditions
keloid
Beyond the preview
Go deeper on IRCT20210524051384N6.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20210524051384N6.